<?xml version="1.0" encoding="UTF-8" standalone="yes"?><response><header><requestMsgID></requestMsgID><responseTime>2025-11-17 18:37:44.3744</responseTime><responseMsgID></responseMsgID><successYN>Y</successYN><resultCode>00</resultCode><resultMsg>NORMAL SERVICE.</resultMsg></header><body><item><biblioSummaryInfoArray><biblioSummaryInfo><applicationDate>2018.12.27</applicationDate><applicationFlag>특허</applicationFlag><applicationNumber>10-2025-7006583</applicationNumber><claimCount>1</claimCount><examinerName> </examinerName><finalDisposal> </finalDisposal><inventionTitle>CD3-델타/엡실론 이형이량체 특이적 항체</inventionTitle><inventionTitleEng>CD3-DELTA/EPSILON HETERODIMER SPECIFIC ANTIBODIES</inventionTitleEng><openDate>2025.03.10</openDate><openNumber>10-2025-0034193</openNumber><originalApplicationDate>2018.12.27</originalApplicationDate><originalApplicationKind>국제출원/분할</originalApplicationKind><originalApplicationNumber>10-2020-7021708</originalApplicationNumber><originalExaminationRequestDate>2025.03.28</originalExaminationRequestDate><originalExaminationRequestFlag>Y</originalExaminationRequestFlag><publicationDate> </publicationDate><publicationNumber> </publicationNumber><registerDate> </registerDate><registerNumber> </registerNumber><registerStatus>공개</registerStatus><translationSubmitDate>2025.02.27</translationSubmitDate></biblioSummaryInfo></biblioSummaryInfoArray><ipcInfoArray><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>C07K 16/28</ipcNumber></ipcInfo><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>A61P 35/00</ipcNumber></ipcInfo><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>A61K 39/00</ipcNumber></ipcInfo></ipcInfoArray><familyInfoArray><familyInfo><familyApplicationNumber>1020207021708</familyApplicationNumber></familyInfo></familyInfoArray><abstractInfoArray><abstractInfo><astrtCont> 신규한 인간 CD3 항원 결합 폴리펩타이드 및 이들의 제조 및 다양한 질환의 치료 및/또는 진단에서의 용도뿐만 아니라, 면역 효과기 세포를 활성화시킬 수 있는 이중특이성 항체 분자 및 다양한 질환의 진단 및/또는 치료에서의 이들의 용도가 제공된다. </astrtCont></abstractInfo></abstractInfoArray><internationalInfoArray><internationalInfo><internationOpenDate>2019.07.04</internationOpenDate><internationOpenNumber>WO2019133761</internationOpenNumber><internationalApplicationDate>2018.12.27</internationalApplicationDate><internationalApplicationNumber>PCT/US2018/067755</internationalApplicationNumber></internationalInfo></internationalInfoArray><claimInfoArray><claimInfo><claim>1. CD3에 결합하는 단리된 단클론성 항원-결합 단백질로서, 상기 단리된 단클론성 항체는 CD3 엡실론(서열번호 23): K73 및 S83; 및 CD3 델타(서열번호 24) K82 및 C93으로부터 선택되는 적어도 하나의 잔기를 포함하는 CD3 상의 에피토프에 결합하는, 단리된 단클론성 항원-결합 단백질.</claim></claimInfo></claimInfoArray><applicantInfoArray><applicantInfo><address>미국 캘리포니아 *****-****, 싸우전드 옥스, 원 암젠 센터 드라이브</address><code>520140515434</code><country>미국</country><engName>TENEObio, Inc.</engName><name>테네오바이오, 인코포레이티드</name></applicantInfo></applicantInfoArray><inventorInfoArray><inventorInfo><address>미국, 캘리포니아 *****, 뉴...</address><code> </code><country>미국</country><engName>SCHELLENBERGER, Ute</engName><name>쉘렌베르거, 유테</name></inventorInfo><inventorInfo><address>미국, 캘리포니아 *****, 뉴...</address><code> </code><country>미국</country><engName>TRINKLEIN, Nathan</engName><name>트린크레인, 나단</name></inventorInfo><inventorInfo><address>미국, 캘리포니아 *****, 뉴...</address><code> </code><country>미국</country><engName>VAN SHOOTEN, Wim</engName><name>반 스호텐, 윔</name></inventorInfo></inventorInfoArray><agentInfoArray><agentInfo><address>서울특별시 송파구 법원로*길 **(문정동) 에이치비즈니스파크 C동 ***호(에스엔케이특허법률사무소)</address><code>919980001509</code><country>대한민국</country><engName>Kim Seong Nam</engName><name>김성남</name></agentInfo></agentInfoArray><priorityInfoArray><priorityInfo><priorityApplicationCountry>미국</priorityApplicationCountry><priorityApplicationDate>2017.12.27</priorityApplicationDate><priorityApplicationNumber>62/610,764</priorityApplicationNumber></priorityInfo></priorityInfoArray><designatedStateInfoArray/><priorArtDocumentsInfoArray/><legalStatusInfoArray><legalStatusInfo><commonCodeName>수리 (Accepted) </commonCodeName><documentEngName>[Divisional Application(International Application)] Patent Application</documentEngName><documentName>[분할출원(국제출원)]특허출원서</documentName><receiptDate>2025.02.27</receiptDate><receiptNumber>1-1-2025-0225801-87</receiptNumber></legalStatusInfo><legalStatusInfo><commonCodeName>수리 (Accepted) </commonCodeName><documentEngName> </documentEngName><documentName>[심사청구]심사청구서·우선심사신청서</documentName><receiptDate>2025.03.28</receiptDate><receiptNumber>1-1-2025-0351634-25</receiptNumber></legalStatusInfo></legalStatusInfoArray><imagePathInfo><docName>1020257006583.jpg</docName><largePath>http://plus.kipris.or.kr/kiprisplusws/fileToss.jsp?arg=6c650beb4cee9ce4122b704b88878c930b842e71cbd0231675bf81a3e0ee5eed9a069e51da6eb18f4781261425aef639ab5cfb69376f29a318677164f3a0f9f6473a094c16f619d4</largePath><path>http://plus.kipris.or.kr/kiprisplusws/fileToss.jsp?arg=ed43a0609e94d6e22d01c5c32ba711cf884750a544b7f42f34015491a4576987eb79ba11e5a6de7a088d0c2113cf620d8935a887f189174bb1f31edbd263c89cca78694bd3412797</path></imagePathInfo><rndInfoArray/></item></body><count><numOfRows>1</numOfRows><pageNo>1</pageNo><totalCount>1</totalCount></count></response>